脾切除治疗遗传性球形红细胞增多症55例临床分析  

55 cases of hereditary spherocytosis treated with splenectomy

作　　者：袁宏伟[1] 刘跃武[1] 李小毅[1] 高维生[1] 

机构地区：[1]中国医学科学院中国协和医科大学北京协和医院基本外科,100730

出　　处：《中华普通外科杂志》2016年第11期944-946,共3页Chinese Journal of General Surgery

摘　　要：目的总结脾切除治疗遗传性球形红细胞增多症的手术适应证、术后并发症的防治及治疗效果。方法回顾性分析北京协和医院1984年10月至2014年10月确诊并行脾切除术的遗传性球形红细胞增多症55例患者的临床资料。结果55例患者均行脾切除术，术后切口感染1例，肺部感染1例，胸腔积液和膈下感染3例，门静脉系统血栓形成4例，术后并发症发生率为14．5％，均经积极治疗后痊愈。结论脾切除是治疗遗传性球形红细胞增多症有效和可靠的手段。Objective To investigate the operative indications, prevention and treatment of postoperative complications and efficacy of spleneetomy in treating hereditary spherocytosis. Methods A retrospective analysis was made on 55 patients of hereditary spheroeytosis and treated with splenectomy in our hospital during October 1984 and October 2014. Results There were one case of incision infection, one case of pulmonary infection, three cases of pleural effusion and subphrenic infection, and four cases of portal vein thrombosis, postoperative complication rate was 14. 5%, all were cured. No recurrence was found during the postoperative follow-ups. Conclusions Splenectomy is effective and safe in treatment of hereditary spherocytosis.

关 键 词：球形红细胞增多 遗传性 脾切除术 手术后并发症 

分 类 号：R657.6[医药卫生—外科学] R555.1[医药卫生—临床医学]